Money Shifts From Biotech to Pharma as Investors Get Defensive
As expected, health care investors took money out of the risky biotech sector and moved into more defensive drug stocks in Monday trading.
Amgen(AMGN Quote), the largest biotech company, is off $2.88, or 4.5%, to $61.25. Genentech(DNA Quote) is down 71 cents, or 1.5%, to $43.85, Biogen(BGEN Quote) is off $2.76, or 4.6% to $57.55, while Human Genome Sciences (HGSI Quote) is off $3.94, or 9.4%, to $37.65. Idec Pharmaceuticals(IDPH Quote), which had a new cancer drug recommended for approval by an Food and Drug Administration advisory panel on Tuesday, was one of the few biotech stocks to actually trade up when the morning bell rang. Since then, Idec has also drifted lower, falling 1.21 cents to $54.93. Interesting, three companies developing oxygen-carrying human blood substitutes are trading higher, although these stocks have a larger-than-normal retail ownership and volume is relatively low. Biopure(BPUR Quote) is up 7 cents to $21.25, Northfield Laboratories (NFLD Quote) is up 4 cents to $15, and Hemosol (HMSL Quote) is up 19 cents to $2.97. None of the companies have products approved for use in the U.S. Drug stocks are holding their own in today's turbulent market. Merck(MRK Quote) is up $1.03, or 1.5%, to $67.13, Pfizer(PFE Quote) is up 25 cents to $38.42 and American Home Products (AHP Quote) is up $1.51, or 2.6%, to $59.68. Bristol-Myers Squibb(BMY Quote) and Johnson & Johnson(JNJ Quote) are also higher, while Schering-Plough (SGP Quote) is off 66 cents to $36.53.
- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,471.58 | 1,108.86 | 2,175.81 | 32.75 |
Oil *
79.69
|
|
UP
126.74
|
UP
13.23
|
UP
31.21
|
UP
0.74
|
10 Yr
3.28%
SPDR Gold
117.38
|
|
+1.23%
|
+1.21%
|
+1.46%
|
+2.31%
|
Data delayed 20 minutes |














